Inventor · disambiguated record
Huiquan Han
Also filed as: HAN HUIQUAN
16 granted patents·12 pending applications·144 citations·filing 2011–2023
93Inventor score
Files withAMGEN INC23SANTA MARIA BIOTHERAPEUTICS INC2AMGEN1CISDI RES & DEVELOPMENT CO LTD1HAN HUIQUAN1
Top patents by PatentIndex Score
28 records- 0198US8999917B2Variant activin receptor polypeptides and uses thereofAMGEN INC·Filed 2013·Granted Apr 7, 2015·48 cites·19 claims
- 0294US9273114B2Stabilized receptor polypeptides and uses thereofAMGEN·Filed 2013·Granted Mar 1, 2016·19 cites·31 claims
- 0393US10308704B2Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2016·Granted Jun 4, 2019·12 cites·8 claims
- 0491US9284364B2Isolated nucleic acid molecule encoding a fusion protein comprising an activin receptorAMGEN INC·Filed 2013·Granted Mar 15, 2016·13 cites·20 claims
- 0591US8999343B2Antibodies that bind myostatin, compositions and methodsHAN HUIQUAN·Filed 2011·Granted Apr 7, 2015·28 cites·10 claims
- 0691US8920798B2Myostatin binding agents, nucleic acids encoding the same, and methods of treatmentAMGEN INC·Filed 2012·Granted Dec 30, 2014·9 cites·28 claims
- 0787US9610327B2Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereofAMGEN INC·Filed 2012·Granted Apr 4, 2017·11 cites·19 claims
- 0887US9453080B2Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2013·Granted Sep 27, 2016·4 cites·21 claims
- 0985US2024327526A1Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 1084US2023295267A1Stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 1176US12383572B2Administration of an anti-activin-a compound to a subjectAMGEN INC·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 1273US11542325B2Anti-activin A antibodies and uses thereofAMGEN INC·Filed 2018·Granted Jan 3, 2023·0 cites·4 claims
- 1373US2021340262A1Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2021·Application pending·0 cites
- 1472US11685770B2Stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2019·Granted Jun 27, 2023·0 cites·6 claims
- 1571US11541070B2Administration of an anti-activin-A compound to a subjectAMGEN INC·Filed 2019·Granted Jan 3, 2023·0 cites·1 claims
- 1671US10981999B2Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2019·Granted Apr 20, 2021·0 cites·7 claims
- 1766US2015175687A1Myostatin binding agentsAMGEN INC·Filed 2014·Application pending·0 cites
- 1863US10266598B2Dual receptor antagonistic antigen-binding proteins and uses thereofAMGEN INC·Filed 2016·Granted Apr 23, 2019·0 cites·11 claims
- 1962US2015086556A1Anti-Activin A Antibodies and Uses ThereofAMGEN INC·Filed 2014·Application pending·0 cites
- 2061US10100109B2Anti-activin A antibodies and uses thereofAMGEN INC·Filed 2016·Granted Oct 16, 2018·0 cites·2 claims
- 2157US2015231206A1Variant activin receptor polypeptides and uses thereofAMGEN INC·Filed 2015·Application pending·0 cites
- 2255US2014294866A1Uses of Myostatin AntagonistsAMGEN INC·Filed 2014·Application pending·0 cites
- 2354US2016152683A1Novel activin receptor and uses thereofAMGEN INC·Filed 2016·Application pending·0 cites
- 2450US2015359850A1Administration of an anti-activin-a compound to a subjectSANTA MARIA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2541US2015322144A1Antibodies that Bind Myostatin, Compositions and MethodsAMGEN INC·Filed 2015·Application pending·0 cites
- 2640US2014220033A1Administration of an Anti-Activin-A Compound to a SubjectSANTA MARIA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2739US12246366B2Intermediate blank connection system for hot-rolled strip headless rolling and connection methodCISDI RES & DEVELOPMENT CO LTD·Filed 2020·Granted Mar 11, 2025·0 cites·10 claims
- 2839US2016038588A1Myostatin Antagonism in Human SubjectsAMGEN INC·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →